NYSE: ITGR · Medical Devices
Integer Holdings (ITGR) fair value: undervalued or overvalued?
As of 1 Oct 2026, Faircurve's model values Integer Holdings (ITGR) at $118.83 a share. The stock last closed at $126.45, which puts the model's fair value 6.0% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 2 Oct 2026. Integer Holdings Corporation.
Faircurve Insights · 1 Oct 2026
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing. The company maintains operations across the United States, Puerto Rico, Costa Rica, and other international regions.
Faircurve's model valued Integer Holdings Corporation at $118.83 a share on 1 Oct 2026, the midpoint of 2,000 simulations. The previous run on 26 Sep 2026 gave the same fair value. The calibrated range over 63 trading days is $99.70 to $144.89; this range is built from the fair value, since there is no live options data for the stock, and it held the price 60% of the time at this horizon. The model's evidence grade is Medium.
Integer Holdings Corporation has an overall quality score of 43 out of 100 against comparable companies. Its quality factors include Profitability at 26, Earnings quality at 56, Growth quality at 24, Capital discipline at 63, Balance sheet at 27, and Stability at 98. Faircurve's model compares it with Haemonetics Corporation, Neogen Corporation, UFP Technologies, Inc., Glaukos Corporation, and Insulet Corp. The stock's median move around its last 8 earnings reports, ignoring direction, was 2.5%.
Written from the figures on this page for the 1 Oct 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
What price range does the model give ITGR?
The calibrated range for ITGR over 63 trading days is $99.70 to $144.89. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 4,327 past valuations, refreshed 26 Sep 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $88.01 to $156.54. In 43% of the simulations the fair value came out above the price the model ran on.
How does ITGR score on business quality?
Integer Holdings's overall quality score is 43 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 26 | 5.4%ROIC | 11.9% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 56 | 0.87xFCF / net income | |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analyst estimate revisions. | 24 | 7.6%Revenue growth, trailing | 13.7% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 63 | 2.3%Net buybacks / market value | 1.5% |
| Balance sheetNet debt to EBITDA and interest coverage. | 27 | 4.29xNet debt / EBITDA | 1.16x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 98 | 0.9 ptsEBITDA margin downside volatility, 5y | 3.8 pts |
How does ITGR compare with similar companies?
The companies in medical devices closest to Integer Holdings in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| LIVN LivaNova PLC | $75.07 | $76.95 | +2.5% | Low evidence grade |
| HAE Haemonetics Corporation | $104.68 | $106.81 | +2.0% | Fairly valued |
| NEOG Neogen Corporation | $12.15 | $12.06 | -0.7% | Fairly valued |
| TMDX TransMedics Group, Inc. | $79.80 | $85.59 | +7.3% | Low evidence grade |
| UFPT UFP Technologies, Inc. | $300.70 | $275.24 | -8.5% | Fairly valued |
| INSP Inspire Medical Systems, Inc. | $69.97 | $70.21 | +0.3% | Low evidence grade |
| GKOS Glaukos Corporation | $163.75 | $147.85 | -9.7% | Fairly valued |
| PODD Insulet Corp. | $131.69 | $142.34 | +8.1% | Fairly valued |
When does ITGR report earnings, and how has the stock reacted?
Integer Holdings's next earnings report is scheduled for 22 Oct 2026. Companies can move their dates.
How ITGR moved around its last 8 earnings reports
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across these 8 reports, ignoring direction, was 2.5%.
| Report date | Two session move |
|---|---|
| 3 Aug 2026 | +3.2% |
| 30 Apr 2026 | +0.4% |
| 19 Feb 2026 | -1.9% |
| 23 Oct 2025 | -33.2% |
| 24 Jul 2025 | -6.3% |
| 24 Apr 2025 | +1.2% |
| 20 Feb 2025 | -9.3% |
| 24 Oct 2024 | -0.6% |
Integer Holdings at a glance
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions.
- Market value
- $4.3B
- Sector
- Healthcare
- Industry
- Medical Devices
- Revenue expected, next twelve months
- $1.9B
- Consensus revenue growth, next fiscal year
- -1.6%
- Analysts with estimates
- 6
- Beta to the US market
- 0.57
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model prices Integer Holdings on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 26 Sep 2026 the model's fair value for ITGR was $118.79. It is unchanged at $118.83 as of 1 Oct 2026. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Integer Holdings's valuation
Is Integer Holdings stock undervalued or overvalued?
On Faircurve's model, ITGR reads as Fairly valued as of 1 Oct 2026. The model's fair value is $118.83 a share against a last close of $126.45, a gap of -6.0%.
What is ITGR's fair value?
$118.83 a share as of 1 Oct 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $88.01 to $156.54.
What price range does the model give ITGR?
$99.70 to $144.89 over 63 trading days. Ranges built this way held the price 60% of the time across 4,327 past valuations, refreshed 26 Sep 2026.
When does Integer Holdings report earnings next?
The next report is scheduled for 22 Oct 2026. Companies can move their dates.
How much has ITGR moved on past earnings reports?
Across its last 8 reports the median two session move was 2.5%, ignoring direction. The largest was -33.2% around the report of 23 Oct 2025.
How confident is the model in this valuation?
The model's evidence grade for ITGR is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.